Skip to content

A new method of KD early diagnosis and individualized treatment established based on the assistant decision support system for Kawasaki disease

A new method of KD early diagnosis and individualized treatment established based on the assistant decision support system for Kawasaki disease

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036868
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kawasaki Disease

Interventions

Sponsors

Shanghai Children's Hospital, Shanghai Jiao Tong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: All children met the diagnostic criteria established by the American Heart Association (AHA) as amended by the American Multidisciplinary Committee in 2017: Fever lasts for 5 days or more, excluding other diseases with similar manifestations; Extremities: Acute phase: erythema of palm (foot), finger (toe) end swelling;Convalescent period: 2 ~ 3 weeks occurrence finger (toe) nail edge desquamination; Pleomorphic rash; Both sides of the ball combined membrane hyperemia without secretions; (5) Changes in the lips and mouth: redness of the lips and mouth, chapped lips, diffuse congestion of the bayberry tongue, mouth and pharynx mucosa; Cervical lymph node lesions (diameter > 1.5 cm), usually unilateral; Control group inclusion criteria: other febrile diseases, meeting one of the following conditions; Fever for 3-5 days; With skin rash, cervical lymph node enlargement, hand and foot swelling, perianal flushing with dandruff and other symptoms; Blood routine examination indicated that CRP>=30mg/L and erythrocyte sedimentation rate >=40mm/h.

Exclusion criteria

Exclusion criteria: The body temperature can be reduced to normal after antibiotic use in patients with fever or respiratory infection who have been previously diagnosed with KD.

Design outcomes

Primary

MeasureTime frame
fever time;C-Reactive Protein;white blood cell count;erythrocyte sedimentation rate (ESR);albumin;cytokine;

Countries

China

Contacts

Public ContactXie Lijian

Shanghai Children's Hospital

naijileix@aliyun.com+86 13916748339

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026